MX2020009556A - Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla. - Google Patents
Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla.Info
- Publication number
- MX2020009556A MX2020009556A MX2020009556A MX2020009556A MX2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A
- Authority
- MX
- Mexico
- Prior art keywords
- stranded
- molecule
- stranded oligorna
- rna molecule
- stranded rna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y605/00—Ligases forming phosphoric ester bonds (6.5)
- C12Y605/01—Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
- C12Y605/01003—RNA ligase (ATP) (6.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a un método para producir una molécula de ARN de hebra única en horquilla capaz de inhibir la expresión de un gen objetivo, el método comprende: (i) una etapa de hibridación para hibridar una primera molécula de oligoARN de hebra única y una segunda molécula de oligoARN de hebra única; y (ii) una etapa de ligación para ligar el extremo 3´ de la primera molécula de oligoARN de hebra única y el extremo 5´ de la segunda molécula de oligoARN de hebra única por una ligasa de la familia Rnl2, en donde una secuencia producida por ligación de la primera molécula de oligoARN de hebra única y la segunda molécula de oligoARN de hebra única comprende una secuencia que inhibe la expresión del gen el gen objetivo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018070423 | 2018-03-30 | ||
PCT/JP2019/013923 WO2019189722A1 (ja) | 2018-03-30 | 2019-03-29 | ヘアピン型一本鎖rna分子の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020009556A true MX2020009556A (es) | 2020-10-05 |
Family
ID=68061953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020009556A MX2020009556A (es) | 2018-03-30 | 2019-03-29 | Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla. |
Country Status (15)
Country | Link |
---|---|
US (2) | US11920131B2 (es) |
EP (1) | EP3778886A4 (es) |
JP (2) | JP6631751B1 (es) |
KR (1) | KR20200136363A (es) |
CN (1) | CN111819280A (es) |
AU (1) | AU2019242331A1 (es) |
BR (1) | BR112020017769A2 (es) |
CA (1) | CA3094160A1 (es) |
IL (1) | IL277346A (es) |
MX (1) | MX2020009556A (es) |
PH (1) | PH12020551487A1 (es) |
RU (1) | RU2020130258A (es) |
TW (1) | TWI772632B (es) |
WO (1) | WO2019189722A1 (es) |
ZA (1) | ZA202005149B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11891602B2 (en) | 2018-10-02 | 2024-02-06 | Toray Industries, Inc. | Method of producing hairpin single-stranded RNA molecules |
KR20220123398A (ko) * | 2019-12-03 | 2022-09-06 | 빔 테라퓨틱스, 인크. | 합성 가이드 rna, 이의 조성물, 방법 및 용도 |
EP4130018A4 (en) * | 2020-03-27 | 2024-04-17 | Sumitomo Chemical Company, Limited | PROCESS FOR THE PRODUCTION OF NUCLEIC ACID OLIGOMERS |
EP4392560A1 (en) * | 2021-08-27 | 2024-07-03 | Peking University | Constructs and methods for preparing circular rna |
CN117660374A (zh) * | 2022-09-08 | 2024-03-08 | 凯莱英医药集团(天津)股份有限公司 | Rna连接酶在寡核苷酸制备上的应用 |
CN115774075B (zh) * | 2023-02-15 | 2023-06-06 | 江苏耀海生物制药有限公司 | 一种基于RP-HPLC分析体外转录产物成分circRNA的方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003532380A (ja) * | 1999-12-02 | 2003-11-05 | モレキュラー ステージング,インコーポレイテッド | 線状自己アニーリングセグメントからの一本鎖環状dnaの産出 |
AU2003256857A1 (en) * | 2002-08-08 | 2004-02-25 | Dharmacon, Inc. | Short interfering rnas having a hairpin structure containing a non-nucleotide loop |
JP5296328B2 (ja) | 2007-05-09 | 2013-09-25 | 独立行政法人理化学研究所 | 1本鎖環状rnaおよびその製造方法 |
US20110055965A1 (en) | 2008-02-15 | 2011-03-03 | Hiroshi Abe | Cycle single-stranded nucleic acid complex and method for producing the same |
WO2011052013A1 (ja) * | 2009-10-29 | 2011-05-05 | 株式会社バイオダイナミクス研究所 | 核酸鎖の結合および修飾方法 |
WO2012005368A1 (ja) | 2010-07-08 | 2012-01-12 | 株式会社ボナック | 遺伝子発現制御のための一本鎖核酸分子 |
EP2639307B1 (en) | 2010-08-03 | 2015-03-04 | Bonac Corporation | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton |
CN103906758B (zh) | 2011-08-25 | 2017-05-10 | 株式会社博纳克 | 配糖体化合物、硫醚的制造方法、醚、醚的制造方法、配糖体化合物的制造方法及核酸的制造方法 |
WO2013077446A1 (ja) * | 2011-11-26 | 2013-05-30 | 株式会社ボナック | 遺伝子発現制御のための一本鎖核酸分子 |
CN104039961A (zh) | 2012-01-07 | 2014-09-10 | 株式会社博纳克 | 具有氨基酸骨架的单链核酸分子 |
WO2014110272A1 (en) | 2013-01-09 | 2014-07-17 | The Penn State Research Foundation | Low sequence bias single-stranded dna ligation |
US10377788B2 (en) | 2015-04-02 | 2019-08-13 | Bonac Corporation | Method for producing glycoside compounds |
WO2017035090A1 (en) | 2015-08-21 | 2017-03-02 | Thomas Jefferson University | Dumbbell-pcr: a method to quantify specific small rna variants with a single nucleotide resolution at terminal sequences |
SG11201803410RA (en) | 2015-10-30 | 2018-05-30 | Bonac Corp | COMPOSITION STABLY CONTAINING SINGLE-STRANDED NUCLEIC ACID MOLECULE THAT SUPPRESSES EXPRESSION OF TGF-ß1 GENE |
GB201612011D0 (en) | 2016-07-11 | 2016-08-24 | Glaxosmithkline Ip Dev Ltd | Novel processes for the production of oligonucleotides |
JP6815601B2 (ja) | 2016-11-01 | 2021-01-20 | スタンレー電気株式会社 | ウルツ鉱構造のZnOS混晶粒子の製造方法 |
JPWO2018182008A1 (ja) | 2017-03-31 | 2020-02-06 | 株式会社ボナック | 遺伝子発現制御機能を有する環状型核酸分子 |
TWI830718B (zh) * | 2018-02-09 | 2024-02-01 | 日商住友化學股份有限公司 | 核酸分子之製造方法 |
US20210115485A1 (en) | 2018-03-30 | 2021-04-22 | Sumitomo Chemical Company, Limited | Method for producing single-strand rna |
-
2019
- 2019-03-29 RU RU2020130258A patent/RU2020130258A/ru unknown
- 2019-03-29 BR BR112020017769-5A patent/BR112020017769A2/pt unknown
- 2019-03-29 JP JP2019520762A patent/JP6631751B1/ja active Active
- 2019-03-29 MX MX2020009556A patent/MX2020009556A/es unknown
- 2019-03-29 US US16/981,329 patent/US11920131B2/en active Active
- 2019-03-29 CA CA3094160A patent/CA3094160A1/en active Pending
- 2019-03-29 KR KR1020207018860A patent/KR20200136363A/ko not_active Application Discontinuation
- 2019-03-29 CN CN201980019534.XA patent/CN111819280A/zh active Pending
- 2019-03-29 EP EP19777814.5A patent/EP3778886A4/en active Pending
- 2019-03-29 TW TW108111164A patent/TWI772632B/zh active
- 2019-03-29 AU AU2019242331A patent/AU2019242331A1/en active Pending
- 2019-03-29 WO PCT/JP2019/013923 patent/WO2019189722A1/ja active Application Filing
- 2019-10-01 JP JP2019181613A patent/JP7363316B2/ja active Active
-
2020
- 2020-08-19 ZA ZA2020/05149A patent/ZA202005149B/en unknown
- 2020-09-14 IL IL277346A patent/IL277346A/en unknown
- 2020-09-16 PH PH12020551487A patent/PH12020551487A1/en unknown
-
2024
- 2024-01-26 US US18/424,639 patent/US20240167033A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3778886A4 (en) | 2022-11-02 |
EP3778886A1 (en) | 2021-02-17 |
CA3094160A1 (en) | 2019-10-03 |
JP6631751B1 (ja) | 2020-01-15 |
PH12020551487A1 (en) | 2021-08-23 |
TW202003842A (zh) | 2020-01-16 |
JP7363316B2 (ja) | 2023-10-18 |
US11920131B2 (en) | 2024-03-05 |
JPWO2019189722A1 (ja) | 2020-04-30 |
WO2019189722A1 (ja) | 2019-10-03 |
BR112020017769A2 (pt) | 2021-01-05 |
JP2019213567A (ja) | 2019-12-19 |
US20240167033A1 (en) | 2024-05-23 |
RU2020130258A (ru) | 2022-05-04 |
TWI772632B (zh) | 2022-08-01 |
ZA202005149B (en) | 2022-01-26 |
IL277346A (en) | 2020-10-29 |
US20210024930A1 (en) | 2021-01-28 |
AU2019242331A1 (en) | 2020-09-10 |
CN111819280A (zh) | 2020-10-23 |
KR20200136363A (ko) | 2020-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020551487A1 (en) | Method for producing hairpin single-stranded rna molecule | |
EA201991369A1 (ru) | Модифицированные направляющие рнк | |
CY1124845T1 (el) | Μεθοδοι παροχης μονοκλωνου rna | |
MX2019014264A (es) | Un metodo de amplificacion de transcriptoma unicelular. | |
MY194798A (en) | Novel adenylosuccinate synthetase and method for producing purine nucleotides using the same | |
MX2019006082A (es) | Dinucleótidos cíclicos como agonistas de sting. | |
PH12019502294A1 (en) | Novel bispecific antigen binding molecules capable of specific binding to cd40 and to fap | |
MX2020009366A (es) | Anticuerpos anti-cd73 y usos de los mismos. | |
CO2020015314A2 (es) | Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso | |
BR122021025194A8 (pt) | Molécula de ácido nucleico, método para obter rna, rna, método para obter um peptídeo ou proteína e usos in vitro ou ex vivo do rna | |
CR20140538A (es) | Métodos y composiciones para la modificación de adn objetivo dirigida por arn y para la modificación de la transcripción dirigida por arn | |
MX2021006745A (es) | Constructos de iarn modificados quimicamente y usos de estos. | |
MX2021007001A (es) | Moleculas inhibidoras de acido nucleico de cadena doble que contienen un tribucle. | |
EP3778901A4 (en) | NEW PROMOTER AND PROCESS FOR THE PRODUCTION OF L-AMINO ACID USING THE PROMOTER | |
AR113458A1 (es) | Método para regular la expresión génica | |
MX2020010802A (es) | Moleculas inhibidoras de acidos nucleicos de caracter bicatenario modificadas con nucleotidos que aumentan la tm. | |
MX2021004454A (es) | Anticuerpos anti-sinucleina. | |
CO2021012310A2 (es) | Composiciones y métodos para tratar laminopatías | |
MX2021013913A (es) | Composiciones y metodos para el tratamiento de enfermedades mediadas por atpasa. | |
CL2021002842A1 (es) | Moléculas inhibidoras de ácido nucleico bicatenario con cadenas de sentido acortadas | |
EP3950881A4 (en) | LIGHT-EMITTING ELEMENT AND METHOD FOR PRODUCTION THEREOF, AND COMPOSITION FOR A LIGHT-EMITTING ELEMENT AND METHOD FOR PRODUCTION THEREOF | |
EP3862431A4 (en) | METHOD FOR PRODUCTION OF HAIRPIN SINGLE-STRANDED RNA MOLECULES | |
AR083445A1 (es) | siARN CONTRA LA FIBROSIS | |
MX2019007110A (es) | Reactivos para el tratamiento de la distrofia muscular oculofaringea (opmd) y uso de estos. | |
MX2021013698A (es) | Composiciones y metodos para el tratamiento de la infeccion por virus de la hepatitis b (vhb). |